Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/13/25 16:06 | 1/10/25 | FATE | Health | BioPrd | Biological Products, (No Diag | Bressi Jerome Charles | CA | O | See Rema | 1 | S | -9 | 1.55 | 0 | -6 | 270 | D | |||||||||||||||
1/13/25 16:05 | 1/10/25 | FATE | Health | BioPrd | Biological Products, (No Diag | Tahl Cindy | CA | O | See Rema | 2 | S | -56 | 3.41 | 0 | -17 | 337 | D | |||||||||||||||
1/13/25 16:04 | 1/10/25 | FATE | Health | BioPrd | Biological Products, (No Diag | Valamehr Bahram | CA | DO | P,CEO | 2 | S | -63 | 3.14 | 0 | -20 | 349 | D | |||||||||||||||
12/26/24 21:00 | 12/20/24 | FATE | Health | BioPrd | Biological Products, (No Diag | Redmile Group, LLC | CA | DT | 1 | S.d | -574 | 1.68 | 0 | -342 | 12,884 | I | ||||||||||||||||
8/7/24 16:01 | 8/6/24 | FATE | Health | BioPrd | Biological Products, (No Diag | Xu Yuan | CA | D | 1 | S | -3 | 4.23 | 0 | -1 | 9 | D | ||||||||||||||||
3/5/24 16:24 | 12/18/23 | FATE | Health | BioPrd | Biological Products, (No Diag | Dulac Edward J III | CA | O | CFO | 5 | S | -83 | 4.61 | 0 | -18 | 118 | D | |||||||||||||||
1/10/24 16:29 | 1/9/24 | FATE | Health | BioPrd | Biological Products, (No Diag | Wolchko J Scott | CA | DO | P,CEO | 1 | S | -63 | 4.37 | 0 | -14 | 371 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |